NCT01486784 2021-06-24A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic LeukemiaAbramson Cancer Center at Penn MedicinePhase 1/2 Terminated27 enrolled 15 charts